Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Harvard Bioscience, Inc. (NASDAQ: HBIO).

Full DD Report for HBIO

You must become a subscriber to view this report.


Recent News from (NASDAQ: HBIO)

Week 20 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 20: Market conditions continue with high volatility. The positive momentum gauge spent another full week in yellow (medium) moving from a value of 61 last week up to a value of 66 this week. The all time low for the positive momentum selection gauge is 8...
Source: SeekingAlpha
Date: May, 14 2018 07:59
Week 19 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 19: Market conditions continue with high volatility. The positive momentum gauge spent another full week in yellow (medium) moving from a value of 52 last week up to a value of 61 this week. The all time low for the positive momentum selection gauge...
Source: SeekingAlpha
Date: May, 06 2018 01:42
Harvard Bioscience's (HBIO) CEO Jeffrey Duchemin on Q1 2018 Results - Earnings Call Transcript
Harvard Bioscience, Inc. (HBIO) Q1 2018 Earnings Conference Call May 2, 2018 4:30 P.M. ET Executives Corey Manchester - Director, Finance and Investor Relations Jeffrey Duchemin - President and Chief Executive Officer Robert Gagnon - Chief Financial Officer Analysts Raymond...
Source: SeekingAlpha
Date: May, 02 2018 21:59
Harvard Bioscience Reports First Quarter 2018 Financial Results
-Reports GAAP and adjusted non-GAAP revenue of $26.8 million and $27.7 million, respectively, an increase of 48% and 15%, respectively- HOLLISTON, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), or the Company, a global developer, manufacturer a...
Source: GlobeNewswire
Date: May, 02 2018 16:01
Harvard Bioscience Subsidiary Multi Channel Systems Launches Beta Cell Screening System for Diabetes Research, Entering New Segment of Electrophysiology Market
HOLLISTON, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Multi Channel Systems (MCS), a subsidiary of Harvard Bioscience, Inc., launched its Beta Cell-System, a new, non-invasive beta cell screening system for diabetes research. The Beta Cell-System leverages MCS’s multi electrode array...
Source: GlobeNewswire
Date: May, 01 2018 17:00
Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants to Enhance Neuroscience Research
ST. PAUL, Minn. and HOLLISTON, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard Bioscience, Inc. (Nasdaq:HBIO) and the global leader in wireless physiologic monitoring, launched two telemetry implants, the PhysioTel™ Digital L03 and L...
Source: GlobeNewswire
Date: May, 01 2018 16:30
Harvard Bioscience Schedules First Quarter 2018 Conference Call for May 2 at 4:30 PM ET
HOLLISTON, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2018 after market trading hours on Wednesday, May 2, ...
Source: GlobeNewswire
Date: April, 23 2018 16:05
Week 16 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 16: Market conditions continue with extreme volatility. The positive momentum gauge has finally moved into the yellow from a value of 14 to a value of 40. Volatility in the market remains at high levels and we have not been above the midpoint value of 60...
Source: SeekingAlpha
Date: April, 15 2018 14:29
Week 15 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 15: Market conditions continue with extreme volatility. The positive momentum gauge remains strongly in the red zone, declining very slightly this past week from a value of 16 to a value of 14, but still in low probability range of positive momentum...
Source: SeekingAlpha
Date: April, 08 2018 05:31
Week 14 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 14: Market conditions continue with extreme volatility. The Market Momentum Gauge indicators are now a subscription based forecasting feature to help gauge the expected momentum conditions for the week ahead. The total return of the Breakout Stock select...
Source: SeekingAlpha
Date: March, 31 2018 09:55

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-224.604.404.604.4087,771
2018-05-214.804.654.804.6084,963
2018-05-184.604.804.804.5586,497
2018-05-174.604.604.704.5589,428
2018-05-164.854.654.904.6094,904

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-2212,51338,43132.5597Cover
2018-05-2117,49453,78032.5288Cover
2018-05-1811,20953,49520.9534Cover
2018-05-1715,21441,09437.0224Short
2018-05-1610,13248,36220.9503Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on HBIO.


About Harvard Bioscience, Inc. (NASDAQ: HBIO)

Logo for Harvard Bioscience, Inc. (NASDAQ: HBIO)

Not available

 

Contact Information

 

 

Current Management

  • Chane Graziano / CEO
  • David Green / President
  • Mark Norige / COO
  • Tom McNaughton / CFO
  • James Warren / CFO

Current Share Structure

  • Market Cap: $174,414,530 - 05/11/2018
  • Issue and Outstanding: 35,594,802 - 03/09/2018

 


Recent Filings from (NASDAQ: HBIO)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: April, 30 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: April, 17 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 06 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 06 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 02 2018
Amendment to a previously filed 8-A12B
Filing Type: 8-A12B/AFiling Source: edgar
Filing Date: March, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 01 2018

 

 


Daily Technical Chart for (NASDAQ: HBIO)

Daily Technical Chart for (NASDAQ: HBIO)


Stay tuned for daily updates and more on (NASDAQ: HBIO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: HBIO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in HBIO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of HBIO and does not buy, sell, or trade any shares of HBIO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/